Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
23.5M
-
Shares change
-
+1.34M
-
Total reported value, excl. options
-
$78M
-
Value change
-
+$8.08M
-
Put/Call ratio
-
0.11
-
Number of buys
-
29
-
Number of sells
-
-22
-
Price
-
$3.32
Significant Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q3 2014
69 filings reported holding CPRX - CATALYST PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2014.
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.5M shares
of 123M outstanding shares and own 19.08% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (6.72M shares), FEDERATED INVESTORS INC /PA/ (3.05M shares), FRANKLIN RESOURCES INC (2.51M shares), VANGUARD GROUP INC (1.88M shares), Visium Asset Management, LP (1.5M shares), Broadfin Capital, LLC (1.4M shares), MORGAN STANLEY (1.24M shares), Opaleye Management Inc. (975K shares), Catalyst Capital Advisors LLC (955K shares), and SPHERA FUNDS MANAGEMENT LTD. (686K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.